Renal Care Group - Martinsville is a medicare approved dialysis facility center in Martinsville, Virginia and it has 24 dialysis stations. It is located in Martinsville City county at 500 Blue Ridge St, Martinsville, VA, 24112. You can reach out to the office of Renal Care Group - Martinsville at (276) 632-8023. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Renal Care Group - Martinsville has the following ownership type - Profit. It was first certified by medicare in January, 1982. The medicare id for this facility is 492527 and it accepts patients under medicare ESRD program.
Name | Renal Care Group - Martinsville |
---|---|
Location | 500 Blue Ridge St, Martinsville, Virginia |
No. of Dialysis Stations | 24 |
Medicare ID | 492527 |
Managed By | Fresenius Medical Care |
Ownership Type | Profit |
Late Shifts | No |
500 Blue Ridge St, Martinsville, Virginia, 24112 | |
(276) 632-8023 | |
News Archive
The hospital admission rate for Blacks with hypertension was 161 per 100,000 people in 2006 - nearly 5 times the hospitalization rate for Whites (33 admissions per 100,000), according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
In a blow to religious colleges and universities across the country, the 7th U.S. Circuit Court of Appeals in Chicago denied Notre Dame's request for an injunction to the ObamaCare birth control mandate that requires the school to provide coverage for contraception.
AVANIR Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the submission of its Complete Response to the October 2006 Approvable Letter issued by the U.S. Food and Drug Administration (FDA) for Zenvia™ (dextromethorphan/quinidine) for the treatment of pseudobulbar affect (PBA). AVANIR expects the FDA to classify the response as a Class 2 resubmission, which would result in an expected review period of 180 days and potential approval of Zenvia in the fourth calendar quarter of 2010.
Research led by Priyanshi Ritwik, DDS, MS, LSUHSC Associate Professor of Pediatric Dentistry at LSU Health Sciences Center New Orleans, reports important findings about side effects and how long they linger after discharge of common oral drugs used to sedate some children during dental procedures.
Recent estimates indicate a prevalence of autism spectrum disorder (ASD) in the United States of 1 in 59 children with a well-established 4:1 male predominance.
› Verified 7 days ago
NPI Number | 1164534988 |
Organization Name | Rcg Martinsville |
Doing Business As | Renal Care Group Of The South, Inc. |
Address | 429 Commonwealth Blvd E Martinsville, Virginia, 24112 |
Phone Number | (276) 632-7091 |
News Archive
The hospital admission rate for Blacks with hypertension was 161 per 100,000 people in 2006 - nearly 5 times the hospitalization rate for Whites (33 admissions per 100,000), according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
In a blow to religious colleges and universities across the country, the 7th U.S. Circuit Court of Appeals in Chicago denied Notre Dame's request for an injunction to the ObamaCare birth control mandate that requires the school to provide coverage for contraception.
AVANIR Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the submission of its Complete Response to the October 2006 Approvable Letter issued by the U.S. Food and Drug Administration (FDA) for Zenvia™ (dextromethorphan/quinidine) for the treatment of pseudobulbar affect (PBA). AVANIR expects the FDA to classify the response as a Class 2 resubmission, which would result in an expected review period of 180 days and potential approval of Zenvia in the fourth calendar quarter of 2010.
Research led by Priyanshi Ritwik, DDS, MS, LSUHSC Associate Professor of Pediatric Dentistry at LSU Health Sciences Center New Orleans, reports important findings about side effects and how long they linger after discharge of common oral drugs used to sedate some children during dental procedures.
Recent estimates indicate a prevalence of autism spectrum disorder (ASD) in the United States of 1 in 59 children with a well-established 4:1 male predominance.
› Verified 7 days ago
Experience Measure | Provider | National Avg. |
---|---|---|
Patients who reported that nephrologists always communicated and cared for them. | 70% | 67% |
Patients who reported that nephrologists usually communicated and cared for them. | 19% | 15% |
Patients who reported that nephrologists sometimes or never communicated and cared for them. | 11% | 18% |
Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 67% | 60% |
Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 26% | 26% |
Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 7% | 14% |
News Archive
The hospital admission rate for Blacks with hypertension was 161 per 100,000 people in 2006 - nearly 5 times the hospitalization rate for Whites (33 admissions per 100,000), according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
In a blow to religious colleges and universities across the country, the 7th U.S. Circuit Court of Appeals in Chicago denied Notre Dame's request for an injunction to the ObamaCare birth control mandate that requires the school to provide coverage for contraception.
AVANIR Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the submission of its Complete Response to the October 2006 Approvable Letter issued by the U.S. Food and Drug Administration (FDA) for Zenvia™ (dextromethorphan/quinidine) for the treatment of pseudobulbar affect (PBA). AVANIR expects the FDA to classify the response as a Class 2 resubmission, which would result in an expected review period of 180 days and potential approval of Zenvia in the fourth calendar quarter of 2010.
Research led by Priyanshi Ritwik, DDS, MS, LSUHSC Associate Professor of Pediatric Dentistry at LSU Health Sciences Center New Orleans, reports important findings about side effects and how long they linger after discharge of common oral drugs used to sedate some children during dental procedures.
Recent estimates indicate a prevalence of autism spectrum disorder (ASD) in the United States of 1 in 59 children with a well-established 4:1 male predominance.
› Verified 7 days ago
Experience Measure | Provider | National Avg. |
---|---|---|
Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible. | 61% | 62% |
Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible. | 28% | 20% |
Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free. | 11% | 18% |
Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 62% | 62% |
Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 28% | 26% |
Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 10% | 12% |
News Archive
The hospital admission rate for Blacks with hypertension was 161 per 100,000 people in 2006 - nearly 5 times the hospitalization rate for Whites (33 admissions per 100,000), according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
In a blow to religious colleges and universities across the country, the 7th U.S. Circuit Court of Appeals in Chicago denied Notre Dame's request for an injunction to the ObamaCare birth control mandate that requires the school to provide coverage for contraception.
AVANIR Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the submission of its Complete Response to the October 2006 Approvable Letter issued by the U.S. Food and Drug Administration (FDA) for Zenvia™ (dextromethorphan/quinidine) for the treatment of pseudobulbar affect (PBA). AVANIR expects the FDA to classify the response as a Class 2 resubmission, which would result in an expected review period of 180 days and potential approval of Zenvia in the fourth calendar quarter of 2010.
Research led by Priyanshi Ritwik, DDS, MS, LSUHSC Associate Professor of Pediatric Dentistry at LSU Health Sciences Center New Orleans, reports important findings about side effects and how long they linger after discharge of common oral drugs used to sedate some children during dental procedures.
Recent estimates indicate a prevalence of autism spectrum disorder (ASD) in the United States of 1 in 59 children with a well-established 4:1 male predominance.
› Verified 7 days ago
Experience Measure | Provider | National Avg. |
---|---|---|
Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. | 85% | 80% |
Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them. | 15% | 20% |
Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 74% | 68% |
Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 24% | 20% |
Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 2% | 12% |
News Archive
The hospital admission rate for Blacks with hypertension was 161 per 100,000 people in 2006 - nearly 5 times the hospitalization rate for Whites (33 admissions per 100,000), according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
In a blow to religious colleges and universities across the country, the 7th U.S. Circuit Court of Appeals in Chicago denied Notre Dame's request for an injunction to the ObamaCare birth control mandate that requires the school to provide coverage for contraception.
AVANIR Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the submission of its Complete Response to the October 2006 Approvable Letter issued by the U.S. Food and Drug Administration (FDA) for Zenvia™ (dextromethorphan/quinidine) for the treatment of pseudobulbar affect (PBA). AVANIR expects the FDA to classify the response as a Class 2 resubmission, which would result in an expected review period of 180 days and potential approval of Zenvia in the fourth calendar quarter of 2010.
Research led by Priyanshi Ritwik, DDS, MS, LSUHSC Associate Professor of Pediatric Dentistry at LSU Health Sciences Center New Orleans, reports important findings about side effects and how long they linger after discharge of common oral drugs used to sedate some children during dental procedures.
Recent estimates indicate a prevalence of autism spectrum disorder (ASD) in the United States of 1 in 59 children with a well-established 4:1 male predominance.
› Verified 7 days ago
Dialysis patients with Hemoglobin data | 49 |
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 10 |
News Archive
The hospital admission rate for Blacks with hypertension was 161 per 100,000 people in 2006 - nearly 5 times the hospitalization rate for Whites (33 admissions per 100,000), according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
In a blow to religious colleges and universities across the country, the 7th U.S. Circuit Court of Appeals in Chicago denied Notre Dame's request for an injunction to the ObamaCare birth control mandate that requires the school to provide coverage for contraception.
AVANIR Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the submission of its Complete Response to the October 2006 Approvable Letter issued by the U.S. Food and Drug Administration (FDA) for Zenvia™ (dextromethorphan/quinidine) for the treatment of pseudobulbar affect (PBA). AVANIR expects the FDA to classify the response as a Class 2 resubmission, which would result in an expected review period of 180 days and potential approval of Zenvia in the fourth calendar quarter of 2010.
Research led by Priyanshi Ritwik, DDS, MS, LSUHSC Associate Professor of Pediatric Dentistry at LSU Health Sciences Center New Orleans, reports important findings about side effects and how long they linger after discharge of common oral drugs used to sedate some children during dental procedures.
Recent estimates indicate a prevalence of autism spectrum disorder (ASD) in the United States of 1 in 59 children with a well-established 4:1 male predominance.
› Verified 7 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
Adult patients getting regular hemodialysis at the center | 84 |
Adult patient months included in Kt/V greater than or equal to 1.2 | 780 |
Percentage of adult patients getting regular hemodialysis at the center | 98 |
Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
The hospital admission rate for Blacks with hypertension was 161 per 100,000 people in 2006 - nearly 5 times the hospitalization rate for Whites (33 admissions per 100,000), according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
In a blow to religious colleges and universities across the country, the 7th U.S. Circuit Court of Appeals in Chicago denied Notre Dame's request for an injunction to the ObamaCare birth control mandate that requires the school to provide coverage for contraception.
AVANIR Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the submission of its Complete Response to the October 2006 Approvable Letter issued by the U.S. Food and Drug Administration (FDA) for Zenvia™ (dextromethorphan/quinidine) for the treatment of pseudobulbar affect (PBA). AVANIR expects the FDA to classify the response as a Class 2 resubmission, which would result in an expected review period of 180 days and potential approval of Zenvia in the fourth calendar quarter of 2010.
Research led by Priyanshi Ritwik, DDS, MS, LSUHSC Associate Professor of Pediatric Dentistry at LSU Health Sciences Center New Orleans, reports important findings about side effects and how long they linger after discharge of common oral drugs used to sedate some children during dental procedures.
Recent estimates indicate a prevalence of autism spectrum disorder (ASD) in the United States of 1 in 59 children with a well-established 4:1 male predominance.
› Verified 7 days ago
Adult patients getting regular peritoneal dialysis at the center | 8 |
Adult patient months included in Kt/V greater than or equal to 1.7 | 36 |
Percentage of adult patients getting regular peritoneal dialysis at the center | |
Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
The hospital admission rate for Blacks with hypertension was 161 per 100,000 people in 2006 - nearly 5 times the hospitalization rate for Whites (33 admissions per 100,000), according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
In a blow to religious colleges and universities across the country, the 7th U.S. Circuit Court of Appeals in Chicago denied Notre Dame's request for an injunction to the ObamaCare birth control mandate that requires the school to provide coverage for contraception.
AVANIR Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the submission of its Complete Response to the October 2006 Approvable Letter issued by the U.S. Food and Drug Administration (FDA) for Zenvia™ (dextromethorphan/quinidine) for the treatment of pseudobulbar affect (PBA). AVANIR expects the FDA to classify the response as a Class 2 resubmission, which would result in an expected review period of 180 days and potential approval of Zenvia in the fourth calendar quarter of 2010.
Research led by Priyanshi Ritwik, DDS, MS, LSUHSC Associate Professor of Pediatric Dentistry at LSU Health Sciences Center New Orleans, reports important findings about side effects and how long they linger after discharge of common oral drugs used to sedate some children during dental procedures.
Recent estimates indicate a prevalence of autism spectrum disorder (ASD) in the United States of 1 in 59 children with a well-established 4:1 male predominance.
› Verified 7 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Renal Care Group - Martinsville with elevated calcium levels.
Patients with hypercalcemia | 98 |
Hypercalcemia patient months | 908 |
Patients with Serumphosphor | 103 |
Patients with Serumphosphor less than 3.5 mg/dL | 12 |
Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 34 |
Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 31 |
Patients with Serumphosphor from 5.6 to 7 mg/dL | 18 |
Patients with Serumphosphor greater than 7 mg/dL | 6 |
News Archive
The hospital admission rate for Blacks with hypertension was 161 per 100,000 people in 2006 - nearly 5 times the hospitalization rate for Whites (33 admissions per 100,000), according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
In a blow to religious colleges and universities across the country, the 7th U.S. Circuit Court of Appeals in Chicago denied Notre Dame's request for an injunction to the ObamaCare birth control mandate that requires the school to provide coverage for contraception.
AVANIR Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the submission of its Complete Response to the October 2006 Approvable Letter issued by the U.S. Food and Drug Administration (FDA) for Zenvia™ (dextromethorphan/quinidine) for the treatment of pseudobulbar affect (PBA). AVANIR expects the FDA to classify the response as a Class 2 resubmission, which would result in an expected review period of 180 days and potential approval of Zenvia in the fourth calendar quarter of 2010.
Research led by Priyanshi Ritwik, DDS, MS, LSUHSC Associate Professor of Pediatric Dentistry at LSU Health Sciences Center New Orleans, reports important findings about side effects and how long they linger after discharge of common oral drugs used to sedate some children during dental procedures.
Recent estimates indicate a prevalence of autism spectrum disorder (ASD) in the United States of 1 in 59 children with a well-established 4:1 male predominance.
› Verified 7 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
Patients included in arterial venous fistula and catheter summaries | 87 |
Patient months included in arterial venous fistula and catheter summaries | 723 |
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 61 |
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 12 |
News Archive
The hospital admission rate for Blacks with hypertension was 161 per 100,000 people in 2006 - nearly 5 times the hospitalization rate for Whites (33 admissions per 100,000), according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
In a blow to religious colleges and universities across the country, the 7th U.S. Circuit Court of Appeals in Chicago denied Notre Dame's request for an injunction to the ObamaCare birth control mandate that requires the school to provide coverage for contraception.
AVANIR Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the submission of its Complete Response to the October 2006 Approvable Letter issued by the U.S. Food and Drug Administration (FDA) for Zenvia™ (dextromethorphan/quinidine) for the treatment of pseudobulbar affect (PBA). AVANIR expects the FDA to classify the response as a Class 2 resubmission, which would result in an expected review period of 180 days and potential approval of Zenvia in the fourth calendar quarter of 2010.
Research led by Priyanshi Ritwik, DDS, MS, LSUHSC Associate Professor of Pediatric Dentistry at LSU Health Sciences Center New Orleans, reports important findings about side effects and how long they linger after discharge of common oral drugs used to sedate some children during dental procedures.
Recent estimates indicate a prevalence of autism spectrum disorder (ASD) in the United States of 1 in 59 children with a well-established 4:1 male predominance.
› Verified 7 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
Patients in facility's Hospitalization Summary | 92 |
Hospitalization Rate in facility | 162 (As Expected) |
Hospitalization Rate: Upper Confidence Limit | 264.2 |
Hospitalization Rate: Lower Confidence Limit | 102.1 |
News Archive
The hospital admission rate for Blacks with hypertension was 161 per 100,000 people in 2006 - nearly 5 times the hospitalization rate for Whites (33 admissions per 100,000), according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
In a blow to religious colleges and universities across the country, the 7th U.S. Circuit Court of Appeals in Chicago denied Notre Dame's request for an injunction to the ObamaCare birth control mandate that requires the school to provide coverage for contraception.
AVANIR Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the submission of its Complete Response to the October 2006 Approvable Letter issued by the U.S. Food and Drug Administration (FDA) for Zenvia™ (dextromethorphan/quinidine) for the treatment of pseudobulbar affect (PBA). AVANIR expects the FDA to classify the response as a Class 2 resubmission, which would result in an expected review period of 180 days and potential approval of Zenvia in the fourth calendar quarter of 2010.
Research led by Priyanshi Ritwik, DDS, MS, LSUHSC Associate Professor of Pediatric Dentistry at LSU Health Sciences Center New Orleans, reports important findings about side effects and how long they linger after discharge of common oral drugs used to sedate some children during dental procedures.
Recent estimates indicate a prevalence of autism spectrum disorder (ASD) in the United States of 1 in 59 children with a well-established 4:1 male predominance.
› Verified 7 days ago
The rate of readmission show you whether patients who were being treated regularly at Renal Care Group - Martinsville were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
Readmission Rate in facility | 17.1 (As Expected) |
Readmission Rate: Upper Confidence Limit | 26 |
Readmission Rate: Lower Confidence Limit | 10.3 |
News Archive
The hospital admission rate for Blacks with hypertension was 161 per 100,000 people in 2006 - nearly 5 times the hospitalization rate for Whites (33 admissions per 100,000), according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
In a blow to religious colleges and universities across the country, the 7th U.S. Circuit Court of Appeals in Chicago denied Notre Dame's request for an injunction to the ObamaCare birth control mandate that requires the school to provide coverage for contraception.
AVANIR Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the submission of its Complete Response to the October 2006 Approvable Letter issued by the U.S. Food and Drug Administration (FDA) for Zenvia™ (dextromethorphan/quinidine) for the treatment of pseudobulbar affect (PBA). AVANIR expects the FDA to classify the response as a Class 2 resubmission, which would result in an expected review period of 180 days and potential approval of Zenvia in the fourth calendar quarter of 2010.
Research led by Priyanshi Ritwik, DDS, MS, LSUHSC Associate Professor of Pediatric Dentistry at LSU Health Sciences Center New Orleans, reports important findings about side effects and how long they linger after discharge of common oral drugs used to sedate some children during dental procedures.
Recent estimates indicate a prevalence of autism spectrum disorder (ASD) in the United States of 1 in 59 children with a well-established 4:1 male predominance.
› Verified 7 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Renal Care Group - Martinsville get infections in their blood each year compared to the number of infections expected for the center based on the national average.
Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
Infection Rate in facility | .74 (As Expected) |
SIR: Upper Confidence Limit | 1.79 |
SIR: Lower Confidence Limit | .24 |
News Archive
The hospital admission rate for Blacks with hypertension was 161 per 100,000 people in 2006 - nearly 5 times the hospitalization rate for Whites (33 admissions per 100,000), according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
In a blow to religious colleges and universities across the country, the 7th U.S. Circuit Court of Appeals in Chicago denied Notre Dame's request for an injunction to the ObamaCare birth control mandate that requires the school to provide coverage for contraception.
AVANIR Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the submission of its Complete Response to the October 2006 Approvable Letter issued by the U.S. Food and Drug Administration (FDA) for Zenvia™ (dextromethorphan/quinidine) for the treatment of pseudobulbar affect (PBA). AVANIR expects the FDA to classify the response as a Class 2 resubmission, which would result in an expected review period of 180 days and potential approval of Zenvia in the fourth calendar quarter of 2010.
Research led by Priyanshi Ritwik, DDS, MS, LSUHSC Associate Professor of Pediatric Dentistry at LSU Health Sciences Center New Orleans, reports important findings about side effects and how long they linger after discharge of common oral drugs used to sedate some children during dental procedures.
Recent estimates indicate a prevalence of autism spectrum disorder (ASD) in the United States of 1 in 59 children with a well-established 4:1 male predominance.
› Verified 7 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Renal Care Group - Martinsville's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
Patients in facility's Transfusion Summary | 80 |
Transfusion Rate in facility | 33.7 (As Expected) |
Transfusion Rate: Upper Confidence Limit | 79.5 |
Transfusion Rate: Lower Confidence Limit | 15.9 |
News Archive
The hospital admission rate for Blacks with hypertension was 161 per 100,000 people in 2006 - nearly 5 times the hospitalization rate for Whites (33 admissions per 100,000), according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
In a blow to religious colleges and universities across the country, the 7th U.S. Circuit Court of Appeals in Chicago denied Notre Dame's request for an injunction to the ObamaCare birth control mandate that requires the school to provide coverage for contraception.
AVANIR Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the submission of its Complete Response to the October 2006 Approvable Letter issued by the U.S. Food and Drug Administration (FDA) for Zenvia™ (dextromethorphan/quinidine) for the treatment of pseudobulbar affect (PBA). AVANIR expects the FDA to classify the response as a Class 2 resubmission, which would result in an expected review period of 180 days and potential approval of Zenvia in the fourth calendar quarter of 2010.
Research led by Priyanshi Ritwik, DDS, MS, LSUHSC Associate Professor of Pediatric Dentistry at LSU Health Sciences Center New Orleans, reports important findings about side effects and how long they linger after discharge of common oral drugs used to sedate some children during dental procedures.
Recent estimates indicate a prevalence of autism spectrum disorder (ASD) in the United States of 1 in 59 children with a well-established 4:1 male predominance.
› Verified 7 days ago
The rate of mortality show you whether patients who were being treated regularly at Renal Care Group - Martinsville lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
Patients in facility's Survival Summary | 411 |
Mortality Rate in facility | 16.1 (As Expected) |
Mortality Rate: Upper Confidence Limit | 20.9 |
Mortality Rate: Lower Confidence Limit | 12.2 |
News Archive
The hospital admission rate for Blacks with hypertension was 161 per 100,000 people in 2006 - nearly 5 times the hospitalization rate for Whites (33 admissions per 100,000), according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
In a blow to religious colleges and universities across the country, the 7th U.S. Circuit Court of Appeals in Chicago denied Notre Dame's request for an injunction to the ObamaCare birth control mandate that requires the school to provide coverage for contraception.
AVANIR Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the submission of its Complete Response to the October 2006 Approvable Letter issued by the U.S. Food and Drug Administration (FDA) for Zenvia™ (dextromethorphan/quinidine) for the treatment of pseudobulbar affect (PBA). AVANIR expects the FDA to classify the response as a Class 2 resubmission, which would result in an expected review period of 180 days and potential approval of Zenvia in the fourth calendar quarter of 2010.
Research led by Priyanshi Ritwik, DDS, MS, LSUHSC Associate Professor of Pediatric Dentistry at LSU Health Sciences Center New Orleans, reports important findings about side effects and how long they linger after discharge of common oral drugs used to sedate some children during dental procedures.
Recent estimates indicate a prevalence of autism spectrum disorder (ASD) in the United States of 1 in 59 children with a well-established 4:1 male predominance.
› Verified 7 days ago
Renal Care Group - Martinsville Location: 500 Blue Ridge St, Martinsville, Virginia, 24112 Phone: (276) 632-8023 |
Davita - Martinsville Dialysis Location: 33 Bridge St, Martinsville, Virginia, 24112 Phone: (276) 632-3743 |
News Archive
The hospital admission rate for Blacks with hypertension was 161 per 100,000 people in 2006 - nearly 5 times the hospitalization rate for Whites (33 admissions per 100,000), according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
In a blow to religious colleges and universities across the country, the 7th U.S. Circuit Court of Appeals in Chicago denied Notre Dame's request for an injunction to the ObamaCare birth control mandate that requires the school to provide coverage for contraception.
AVANIR Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the submission of its Complete Response to the October 2006 Approvable Letter issued by the U.S. Food and Drug Administration (FDA) for Zenvia™ (dextromethorphan/quinidine) for the treatment of pseudobulbar affect (PBA). AVANIR expects the FDA to classify the response as a Class 2 resubmission, which would result in an expected review period of 180 days and potential approval of Zenvia in the fourth calendar quarter of 2010.
Research led by Priyanshi Ritwik, DDS, MS, LSUHSC Associate Professor of Pediatric Dentistry at LSU Health Sciences Center New Orleans, reports important findings about side effects and how long they linger after discharge of common oral drugs used to sedate some children during dental procedures.
Recent estimates indicate a prevalence of autism spectrum disorder (ASD) in the United States of 1 in 59 children with a well-established 4:1 male predominance.
› Verified 7 days ago